Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

Dupilumab for skin problems might reactivate hair loss in some patients.

Bone marrow-derived stem cells improved healing and reduced scarring in second-degree burns in rats.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

IL-36α helps grow new hair follicles and speeds up wound healing.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

Garden cress extract may help treat skin inflammation and androgen-related disorders.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

Magnesium oxide-infused membranes help heal wounds faster by reducing inflammation and promoting skin and hair follicle growth.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Serenoa repens and N-acetyl glucosamine/milk proteins complex may help with hair growth and prevent hair loss.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

Dupilumab can improve both atopic dermatitis and alopecia universalis.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

BLH308, made from persimmon leaf, green tea, and sophora fruit, may help reduce hair loss by fighting oxidative stress and inflammation.

Activating TLR5 in the gut can extend lifespan and improve health in aged mice.

COVID-19 vaccines have been linked to an increase in hair loss conditions.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.